Received Nov 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | OT |
Pericarditis; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): MOC20251030000016 (Moderna). A patient (age and gender not provided) received BNT162b2 (BNT162B2), in 2021 as dose number unknown, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERICARDITIS (life-threatening, hospitalization, medically significant) with onset 2021, outcome "recovered". The clinical course was reported as follows: The patient received the Pfizer vaccine for the coronavirus in the spring of 2021, three weeks later the patient was in the Intensive Care Unit (ICU) for a short stay with pericarditis. The patient was hospitalized for pericarditis (start date: 2021). No follow-up attempts are possible. Batch/lot number is not provided, and it cannot be obtained.